Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
biotech
7
×
deals
7
×
life sciences
national blog main
san francisco blog main
7
×
vc
7
×
boston blog main
national top stories
new york blog main
san diego blog main
startups
boston top stories
san diego top stories
new york top stories
san francisco top stories
venture capital
cancer
gene therapy
ipo
avalon ventures
boston
correlation ventures
eli lilly
funding
hemophilia
indiana blog main
innovation
laura shawver
medicxi
orbimed
ra capital management
raleigh-durham blog main
rtw investments
san diego
san francisco
seattle blog main
synthorx
acetylon pharmaceuticals
adeno-associated virus
administration
What
drugs
new
startup
advance
biology
biotech
cytokine
developing
enhanced
gene
medicines
patients
san
suite
synthetic
synthorx
therapy
today
aiming
aims
ambys
approach
based
becker
beta
big
billions
bio
biologic
bionics
blood
called
closed
company
control
crude
cutting
deadly
deal
debuted
Language
unset
Current search:
vc
×
deals
×
photo
×
biotech
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs